tm logo
AMX MEDICAL
Live/Pending
PUBLISHED FOR OPPOSITION

on 03 Dec 2024

Last Applicant/ Owned by

Suite 900 - #3585

Miami

FL

33130

Serial Number

98336676 filed on 30th Dec 2023

Registration Number

N/A

Correspondent Address

Daniel C. Neustadt

Daniel C. Neustadt Holland & Knight LLP

Washington, DC 20006

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AMX MEDICAL

Software as a service (SAAS) services featuring software for searching job postings for temporary and permanent staffing in the field of healthcare and nursing; Software as a service (SAAS) services featuring software for facilitating the qualification, procurement, placement and scheduling of temporary and permanent personnel in the field of healthcare and nursing

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Software as a service (SAAS) services featuring software for searching job postings for temporary and permanent staffing in the field of healthcare and nursing; Software as a service (SAAS) services featuring software for facilitating the qualification, procurement, placement and scheduling of temporary and permanent personnel in the field of healthcare and nursing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98336676

Mark Type

No Service Mark

Attorney Docket Number

No 220508.11

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Dec 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03rd Dec 2024PUBLISHED FOR OPPOSITION
27th Nov 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
05th Nov 2024EXAMINER'S AMENDMENT ENTERED
05th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
05th Nov 2024EXAMINERS AMENDMENT E-MAILED
05th Nov 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05th Nov 2024EXAMINERS AMENDMENT -WRITTEN
04th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED